The startup incubator Y Combinator plans to fund more early-stage drug makers, with a partnership designed to bring academic spinouts developing small-molecule drugs into its famed accelerator program. And in a Silicon Valley twist, the compounds it’s backing will often be recommended by an algorithm.
{iframe}https://www.statnews.com/2019/04/29/y-combinator-startups-small-molecule-drugs/{/iframe}